Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

International Flavors & Fragrances Inc

NYSE: IFF · Industrial Applications and Services · 3 alerts · CIK 51253

Share price
$79.43Close, Nov 17
Market cap
$19.9B
Shares outstanding
250.39MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Industrial Organic ChemicalsSIC 2860

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All International Flavors & Fragrances Inc filings on SEC EDGAR ↗

4:32 PM ET 10-Q
Financial Results

International Flavors & Fragrances Q3 2026 Results: Net Loss of $55M

For the nine months ended September 30, 2026, IFF reported net sales of $5.8 billion and a net income of $166 million, a significant recovery from a $377 million loss in the prior year period. The company recorded a $236 million loss on assets classified as held for sale during the third quarter, while also completing $588 million in treasury share repurchases year-to-date.

Key figure
Net loss $55M
4:20 PM ET 8-K
Financial Results

International Flavors & Fragrances Financial Results

IFF reported third quarter 2026 financial results with net sales of $1.94 billion, representing a 4% increase over the prior year. The company raised the low end of its full-year 2026 guidance and confirmed it recently completed a $500 million share repurchase program.

Term
Q3 2026

“IFF delivered a solid third quarter, with improved sales and profitability across all divisions. Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modestly as we continue to strengthen the business. We also generated strong cash flow through the first nine months of 2026 and recently completed our $500 million accelerated share repurchase program. The separation of Food Ingredients is progressing well, and we are on track with our timeline to close.”

Erik Fyrwald, CEO of IFF

“Heading into year-end, we are raising the low end of our full-year financial guidance ranges, supported by our year-to-date performance. Volumes remain solid as customers continue to value our strong R&D and innovation. At the same time, we expect fourth-quarter profitability to be softer, particularly in Health & Biosciences, reflecting higher costs as well as reinvestments to strengthen the business. Amid changing macroeconomic conditions, we remain focused on what we can control and are delivering on the financial commitments we set out earlier this year. Our continued execution and these actions give us confidence to deliver results within our full-year financial outlook and our ability to create long-term value for shareholders.”

Erik Fyrwald, CEO of IFF

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.